Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Astragalus root-containing pharmaceutical composition for lowering blood fat

A composition, the technology of astragalus, applied in the field of blood lipid-lowering pharmaceutical compositions, can solve the problems of overly large prescriptions, unfavorable promotion and application, and high prices

Inactive Publication Date: 2015-02-25
CHENGDU GUORUI PHARMA TECH
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, there are many Chinese patent medicines for the treatment of hyperlipidemia, some of which have too large prescriptions and unclear curative effects, and some are quite expensive due to the use of precious medicinal materials in the prescriptions
These make it unfavorable to promote the price application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] The blood lipid-lowering pharmaceutical composition described in the present embodiment is made of the following raw materials:

[0032] Astragalus 12g, Lonicera 6g, Gastrodia elata 6g, Rhodiola rosea 6g, Divine Comedy 6g, Puhuang 3g and Chenpi 3g.

[0033] The above-mentioned raw materials are prepared into granules, and the preparation method is as follows:

[0034] Add 10 times the volume of 70% ethanol to the raw materials in the above weight ratio, reflux and extract three times, the extraction time is 2.0h, 1.5h, 1.5h respectively, filter, combine the filtrates for 3 times, recover the ethanol and concentrate, and then concentrate each The solution is mixed evenly, dried, then added with 100g of sucrose, mixed evenly, and divided into bags to obtain a pharmaceutical composition of granules.

Embodiment 2

[0036] The blood lipid-lowering pharmaceutical composition described in this embodiment is made of the following raw materials:

[0037] Astragalus 5g, Lonicera 18g, Gastrodia elata 3g, Rhodiola rosea 12g, Divine Comedy 12g, Puhuang 2g and tangerine peel 2g.

[0038] The above-mentioned raw materials are prepared into tablets, and the preparation method is as follows:

[0039] Add 10 times the volume of 70% ethanol to the raw materials in the above weight ratio, reflux and extract three times, the extraction time is 2.0h, 1.5h, 1.5h respectively, filter, combine the filtrates for 3 times, recover the ethanol and concentrate, and then concentrate each The mixture is uniformly mixed, dried, then mixed with 100g of starch and 10g of povidone, and prepared into a pharmaceutical composition of tablets by using the existing tabletting technology.

Embodiment 3

[0041] The blood lipid-lowering pharmaceutical composition described in this embodiment is made of the following raw materials:

[0042] Astragalus 18g, Lonicera 3g, Gastrodia elata 15g, Rhodiola rosea 5g, Divine Comedy 4g, Puhuang 8g and tangerine peel 8g.

[0043] Above-mentioned raw material is prepared into powder, and preparation method is as follows:

[0044] Add 9 times the volume of 60% ethanol to the raw materials in the above weight ratio, reflux extraction three times, the extraction time is 2.0h, 1.5h, 1.5h respectively, filter, combine the filtrates for 3 times, recover the ethanol and concentrate, and then concentrate each Liquid mixed evenly, dried, then mixed with 100g dextrin, made into powder according to the preparation technology of powder, and packed into bags.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an astragalus root-containing pharmaceutical composition for lowering blood fat. The pharmaceutical composition is prepared from astragalus root, honeysuckle, gastrodia tuber, rhodiola rosea, medicated leaven, cattail pollen and dried tangerine peel. Proofed by pharmacological experiments, the pharmaceutical composition disclosed by the invention has a very good blood fat lowering effect, is definite in treatment effect, low in drug dosage and simple in prescription, is free from toxic or side effects on human bodies and is beneficial to popularization and application.

Description

technical field [0001] The present invention relates to a kind of medicine composition for lowering blood fat, especially to a kind of medicine composition for lowering blood fat containing Radix Astragali, in particular to a medicine composed of Astragalus, Honeysuckle, Gastrodia elata, Rhodiola rosea, Divine Comedy, Puhuang and Tangerine Peel. Pharmaceutical composition made from raw materials. Background technique [0002] With the continuous improvement of people's living standards, the incidence of hyperlipidemia is on the rise, and hyperlipidemia is the cause of coronary atherosclerotic heart disease (coronary heart disease), arteriosclerosis, fatty liver, diabetes, obesity important factors of disease. Therefore, it is of great practical significance to find efficient and non-toxic blood lipid-lowering drugs. [0003] Lipoproteins refer to proteins combined with lipids, including very low-density lipoproteins (VLDL), low-density lipoproteins (LDL), and high-density ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8988A61P3/06
CPCA61K36/355A61K9/0053A61K9/14A61K9/16A61K9/2027A61K9/2059A61K9/48A61K36/00A61K36/41A61K36/481A61K36/752A61K36/88A61K36/8988A61K2236/333A61K2236/39A61K2236/51A61K2236/53A61K2300/00
Inventor 李文军张太君张玲
Owner CHENGDU GUORUI PHARMA TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com